24
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Essential roles of exosome and circRNA_101093 on ferroptosis desensitization in lung adenocarcinoma

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Background

          Resistance to ferroptosis, a regulated cell death caused by iron‐dependent excessive accumulation of lipid peroxides, has recently been linked to lung adenocarcinoma (LUAD). Intracellular antioxidant systems are required for protection against ferroptosis. The purpose of the present study was to investigate whether and how extracellular system desensitizes LUAD cells to ferroptosis.

          Methods

          Established human lung fibroblasts MRC‐5, WI38, and human LUAD H1650, PC9, H1975, H358, A549, and H1299 cell lines, tumor and matched normal adjacent tissues of LUAD, and plasma from healthy individuals and LUAD patients were used in this study. Immunohistochemistry and immunoblotting were used to analyze protein expression, and quantitative reverse transcription‐PCR was used to analyze mRNA expression. Cell viability, cell death, and the lipid reactive oxygen species generation were measured to evaluate the responses to ferroptosis. Exosomes were observed using transmission electron microscope. The localization of arachidonic acid (AA) was detected using click chemistry labeling followed by confocal microscopy. Interactions between RNAs and proteins were detected using RNA pull‐down, RNA immunoprecipitation and photoactivatable ribonucleoside‐enhanced crosslinking and immunoprecipitation methods. Proteomic analysis was used to investigate RNA‐regulated proteins, and metabolomic analysis was performed to analyze metabolites. Cell‐derived xenograft, patient‐derived xenograft, cell‐implanted intrapulmonary LUAD mouse models and plasma/tissue specimens from LUAD patients were used to validate the molecular mechanism.

          Results

          Plasma exosome from LUAD patients specifically reduced lipid peroxidation and desensitized LUAD cells to ferroptosis. A potential explanation is that exosomal circRNA_101093 (cir93) maintained an elevation in intracellular cir93 in LUAD to modulate AA, a poly‐unsaturated fatty acid critical for ferroptosis‐associated increased peroxidation in the plasma membrane. Mechanistically, cir93 interacted with and increased fatty acid‐binding protein 3 (FABP3), which transported AA and facilitated its reaction with taurine. Thus, global AA was reduced, whereas N‐arachidonoyl taurine (NAT, the product of AA and taurine) was induced. Notably, the role of NAT in suppressing AA incorporation into the plasma membrane was also revealed. In pre‐clinical in vivo models, reducing exosome improved ferroptosis‐based treatment.

          Conclusion

          Exosome and cir93 are essential for desensitizing LUAD cells to ferroptosis, and blocking exosome may be helpful for future LUAD treatment.

          Related collections

          Most cited references59

          • Record: found
          • Abstract: found
          • Article: not found

          Ferroptosis: A Regulated Cell Death Nexus Linking Metabolism, Redox Biology, and Disease

          Ferroptosis is a form of regulated cell death characterized by the iron-dependent accumulation of lipid hydroperoxides to lethal levels. Emerging evidence suggests that ferroptosis represents an ancient vulnerability caused by the incorporation of polyunsaturated fatty acids into cellular membranes, and cells have developed complex systems that exploit and defend against this vulnerability in different contexts. The sensitivity to ferroptosis is tightly linked to numerous biological processes, including amino acid, iron, and polyunsaturated fatty acid metabolism, and the biosynthesis of glutathione, phospholipids, NADPH, and coenzyme Q10. Ferroptosis has been implicated in the pathological cell death associated with degenerative diseases (i.e., Alzheimer's, Huntington's, and Parkinson's diseases), carcinogenesis, stroke, intracerebral hemorrhage, traumatic brain injury, ischemia-reperfusion injury, and kidney degeneration in mammals and is also implicated in heat stress in plants. Ferroptosis may also have a tumor-suppressor function that could be harnessed for cancer therapy. This Primer reviews the mechanisms underlying ferroptosis, highlights connections to other areas of biology and medicine, and recommends tools and guidelines for studying this emerging form of regulated cell death.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            The biology and management of non-small cell lung cancer.

            Important advancements in the treatment of non-small cell lung cancer (NSCLC) have been achieved over the past two decades, increasing our understanding of the disease biology and mechanisms of tumour progression, and advancing early detection and multimodal care. The use of small molecule tyrosine kinase inhibitors and immunotherapy has led to unprecedented survival benefits in selected patients. However, the overall cure and survival rates for NSCLC remain low, particularly in metastatic disease. Therefore, continued research into new drugs and combination therapies is required to expand the clinical benefit to a broader patient population and to improve outcomes in NSCLC.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Ferroptosis: process and function.

              Ferroptosis is a recently recognized form of regulated cell death. It is characterized morphologically by the presence of smaller than normal mitochondria with condensed mitochondrial membrane densities, reduction or vanishing of mitochondria crista, and outer mitochondrial membrane rupture. It can be induced by experimental compounds (e.g., erastin, Ras-selective lethal small molecule 3, and buthionine sulfoximine) or clinical drugs (e.g., sulfasalazine, sorafenib, and artesunate) in cancer cells and certain normal cells (e.g., kidney tubule cells, neurons, fibroblasts, and T cells). Activation of mitochondrial voltage-dependent anion channels and mitogen-activated protein kinases, upregulation of endoplasmic reticulum stress, and inhibition of cystine/glutamate antiporter is involved in the induction of ferroptosis. This process is characterized by the accumulation of lipid peroxidation products and lethal reactive oxygen species (ROS) derived from iron metabolism and can be pharmacologically inhibited by iron chelators (e.g., deferoxamine and desferrioxamine mesylate) and lipid peroxidation inhibitors (e.g., ferrostatin, liproxstatin, and zileuton). Glutathione peroxidase 4, heat shock protein beta-1, and nuclear factor erythroid 2-related factor 2 function as negative regulators of ferroptosis by limiting ROS production and reducing cellular iron uptake, respectively. In contrast, NADPH oxidase and p53 (especially acetylation-defective mutant p53) act as positive regulators of ferroptosis by promotion of ROS production and inhibition of expression of SLC7A11 (a specific light-chain subunit of the cystine/glutamate antiporter), respectively. Misregulated ferroptosis has been implicated in multiple physiological and pathological processes, including cancer cell death, neurotoxicity, neurodegenerative diseases, acute renal failure, drug-induced hepatotoxicity, hepatic and heart ischemia/reperfusion injury, and T-cell immunity. In this review, we summarize the regulation mechanisms and signaling pathways of ferroptosis and discuss the role of ferroptosis in disease.
                Bookmark

                Author and article information

                Contributors
                yongxia.qiao@shsmu.edu.cn
                yyc2166@sjtu.edu.cn
                karajan2@163.com , Jiayi.wang@sjtu.edu.cn
                Journal
                Cancer Commun (Lond)
                Cancer Commun (Lond)
                10.1002/(ISSN)2523-3548
                CAC2
                Cancer Communications
                John Wiley and Sons Inc. (Hoboken )
                2523-3548
                20 February 2022
                April 2022
                : 42
                : 4 ( doiID: 10.1002/cac2.v42.4 )
                : 287-313
                Affiliations
                [ 1 ] Department of Laboratory Medicine Shanghai Chest Hospital Shanghai Jiao Tong University School of Medicine Shanghai 200030 P. R. China
                [ 2 ] Department of Thoracic Surgery Shanghai Chest Hospital Shanghai Jiao Tong University School of Medicine Shanghai 200030 P. R. China
                [ 3 ] Shanghai Institute of Thoracic Oncology Shanghai Chest Hospital Shanghai Jiao Tong University School of Medicine Shanghai 200030 P. R. China
                [ 4 ] Shanghai Lung Cancer Center Shanghai Chest Hospital Shanghai Jiao Tong University School of Medicine Shanghai 200030 P. R. China
                [ 5 ] Department of Bio‐bank Shanghai Chest Hospital Shanghai Jiao Tong University School of Medicine Shanghai 200030 P. R. China
                [ 6 ] Shanghai Municipal Hospital of Traditional Chinese Medicine Shanghai University of Traditional Chinese Medicine Shanghai 200071 P. R. China
                [ 7 ] Bio‐X Institutes Key Laboratory for the Genetics of Developmental and Neuropsychiatric disorder Shanghai Jiao Tong University Shanghai 200030 P. R. China
                [ 8 ] Department of Clinical Laboratory Medicine Shanghai Tenth People's Hospital of Tongji University Shanghai 200072 P. R. China
                [ 9 ] School of Public Health Shanghai Jiao Tong University School of Medicine Shanghai 200025 P. R. China
                Author notes
                [*] [* ] Correspondence

                Yongxia Qiao, School of Public Health, Shanghai Jiao Tong University School of Medicine, No.227, South Chongqing Rd, Shanghai 200025, P. R. China.

                Email: yongxia.qiao@ 123456shsmu.edu.cn

                Yongchun Yu, Shanghai Institute of Thoracic Oncology, Shanghai Chest Hospital, Shanghai Jiao Tong University, No. 241 West Huaihai Road, Shanghai 200030, P. R. China.

                Email: yyc2166@ 123456sjtu.edu.cn

                Jiayi Wang, Department of Laboratory Medicine, Shanghai Chest Hospital, Shanghai Jiao Tong University, No. 241, West Huaihai Rd, Shanghai 200030, P. R. China.

                Email: karajan2@ 123456163.com , Jiayi.wang@ 123456sjtu.edu.cn

                [†]

                These authors contributed equally to this work.

                Author information
                https://orcid.org/0000-0003-1688-2864
                Article
                CAC212275
                10.1002/cac2.12275
                9017758
                35184419
                e6275c2d-3680-4838-b652-f326c46de10f
                © 2022 The Authors. Cancer Communications published by John Wiley & Sons Australia, Ltd. on behalf of Sun Yat‐sen University Cancer Center

                This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.

                History
                : 20 November 2021
                : 24 August 2021
                : 08 February 2022
                Page count
                Figures: 8, Tables: 0, Pages: 27, Words: 15710
                Funding
                Funded by: National Natural Science Foundation of China , doi 10.13039/501100001809;
                Award ID: 81871907
                Award ID: 81822029
                Award ID: 81872288
                Award ID: 82173015
                Award ID: 81902315
                Award ID: 81902869
                Award ID: 81774291
                Funded by: Shanghai Municipal Education Commission‐Gaofeng Clinical Medicine
                Award ID: 20191834
                Funded by: Project of Clinical Research Supporting System
                Funded by: Clinical Medicine First‐class Discipline
                Funded by: Shanghai Municipal Education Commission and Shanghai Education Development Foundation
                Award ID: 18CG16
                Funded by: Shanghai Sailing Program
                Award ID: 19YF1444800
                Funded by: Science and technology commission of Shanghai municipality project
                Award ID: 19140902600
                Award ID: 21140902800
                Funded by: Shanghai Chest Hospital , doi 10.13039/501100008837;
                Award ID: 2018YNJCM01
                Award ID: 2019YNJCM06
                Award ID: 2021YNZYJ01
                Award ID: 2021YNZYY01
                Award ID: 2021YNZYY02
                Categories
                Original Article
                Original Articles
                Custom metadata
                2.0
                April 2022
                Converter:WILEY_ML3GV2_TO_JATSPMC version:6.1.4 mode:remove_FC converted:19.04.2022

                exosome,circrna_101093,ferroptosis,desensitization,lung adenocarcinoma,lipid peroxidation,poly‐unsaturated fatty acid,taurine,n‐arachidonoyl taurine,rna‐protein interaction

                Comments

                Comment on this article